SALT LAKE CITY and TORONTO, Sept. 29, 2014/ PRNewswire/ EastGate Acquisitions Corporation, an emerging pharmaceutical company exploring drug delivery innovations in the development of novel formulations and alternative dosage forms of existing biologically active molecules, announces that it has entered into a licensing agreement with Purine Phar
Flamel Technologies today announced the results of a First-in-Man clinical study in healthy volunteers using its proprietary LiquiTime drug delivery platform applied to ibuprofen, a broadly used medication for pain. The next step will be to move this product into a pivotal bioequivalence study in 2015, "said Mike Anderson, Chief Executive Office
The global implantable drug delivery devices market will notch US$ 21.1 billion by 2018, recording a CAGR of 8.8% from 2012 through 2018, says the report "Implantable Drug Delivery Devices Market- Global Industry Analysis, Size, Share, Trends and Forecast 2012- 2018" by Transparency Market Research, a U.S.-based market intelligence company.
Insys Therapeutics, Inc., a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to its pharmaceutical cannabidiol for the treatment of glioma, which comprises approximately eighty...
Fast Market Research recommends " Pantec Biosolutions AG- Product Pipeline Analysis, 2014 Update" from GlobalData, now availableBoston, MA 09/26/2014 Pantec Biosolutions AG is a transdermal drug delivery solution provider. Pantec is headquartered in Ruggell, Liechtenstein. View Full Report Details and Table of Contents This report is a source
New Medical Devices research report from GlobalData is now available from Fast Market ResearchBoston, MA 09/26/2014 Consort Medical plc is a healthcare company with focus on medical device technologies for drug delivery. Major products offered by Consort Medical include metered dose inhalers, dry powder devices, integrated dose counters, actu
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema. FDA approval of ILUVIEN entitles pSivida to a $25 million milestone from its licensee Alimera Sciences. pSi
Researchers at Orion Pharma Release New Data on Pharmaceutical Research. By a News Reporter-Staff News Editor at Drug Week A new study on Drugs and Therapies is now available. According to news reporting from Espoo, Finland, by NewsRx journalists, research stated, "Nanocrystal-based drug delivery systems provide important tools for ocular formula
Contract notice: Characterization of bioavailability, efficacy and possible toxicity of molecules transmitted through drug delivery systems for ophthalmic developed within the activity. This contract is divided into lots: no Estimated value excluding VAT: 400 000 EUR Deposits and Guarantees required: Provisional security 2% of the estimated amount.
San Francisco, CA 09/25/2014 CMEA Capital portfolio company Neos Therapeutics, Inc., a specialty pharmaceutical company with highly differentiated proprietary oral drug delivery technologies and a late-stage pipeline of innovative controlled release products for ADHD, announced that it has acquired all commercialization rights to its Hydrocod
Implantable drug delivery devices are the medical devices, which enable site specific drug administration. It also helps in minimizing the doses of drug in order to reduce potential side effects. These devices facilitate sustained release of a therapeutic agent.Portland, OR 09/25/2014 Implantable drug delivery devices are the medical devices,
Pharmaceutical packaging equipment helps in reducing time for packaging of pharmaceutical products which helps to increase production and innovations in drug delivery systems and personalized drugs. Browse the full Pharmaceutical Packaging Equipment Market report at:...
Transparency Market Research has published a new report titled "Implantable Drug Delivery Devices Market- Global Industry Analysis, Size, Share, Trends And Forecast 2012- 2018" to its report store.Albany, NY 09/24/2014 The global implantable drug delivery devices market will notch US$ 21.1 billion by 2018, recording a CAGR of 8.8% from 2012 t
Dublin- Research and Markets has announced the addition of the "Inhaled Drug Delivery" conference to their offering. Venue: The Rembrandt Hotel, London. Dr Steve Nichols, OINDP Specialist Consultant, UK.
According to news originating from Piscataway, New Jersey, by NewsRx correspondents, research stated, "Liposomes are an important class of colloidal drug delivery systems, yet the clinical applications of conventional liposomes can be hampered by poor colloidal and biological stabilities. Our news journalists obtained a quote from the research from
New Drug Delivery Systems Findings Has Been Reported by Investigators at Indian Institute of Technology. According to news reporting originating in Kharagpur, India, by NewsRx journalists, research stated, "Multifunctional mesoporous silica-coated superparamagnetic manganese ferrite nanopartides were synthesized and evaluated for targeted drug...
New Drug Delivery Systems Study Findings Have Been Reported by Investigators at Silpakorn University. According to news reporting from Nakorn Panom, Thailand, by NewsRx journalists, research stated, "The aim of this study is to develop hydrophobic chitosan sponges by using novel simple preparation technique in which hydrophobicity of chitosan was..
By a News Reporter-Staff News Editor at Biotech Week Researchers detail new data in Pharmacokinetics. According to news reporting originating from Ghaziabad, India, by NewsRx correspondents, research stated, "Solid lipid nanoparticle is an efficient lipid based drug delivery system which can enhance the bioavailability of poorly water soluble dru
Researchers' Work from City University of Hong Kong Focuses on Drug Delivery Systems. According to news reporting out of Hong Kong, People's Republic of China, by NewsRx editors, research stated, "Many biological barriers are of great importance. Our news journalists obtained a quote from the research from the City University of Hong Kong, "Cell me
Research and Markets has announced the addition of the "Large Volume Wearable Injectors- 2nd Edition" report to their offering. The injectable drug delivery market holds significant potential for the future. From the conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle free injectors and.